focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdriatic Metal. Regulatory News (ADT1)

Share Price Information for Adriatic Metal. (ADT1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 245.00
Bid: 244.00
Ask: 245.00
Change: -5.00 (-2.00%)
Spread: 1.00 (0.41%)
Open: 252.00
High: 253.50
Low: 243.50
Prev. Close: 250.00
ADT1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, Director Dealing and TVR

27 Sep 2022 16:21

RNS Number : 8883A
Adriatic Metals PLC
27 September 2022
 

27 September 2022

 

 Adriatic Metals PLC 

("Adriatic Metals" or the "Company")

 

Exercise of Options, Director Dealing and Total Voting Rights

Adriatic Metals PLC (ASX:ADT, LSE:ADT1, OTCQX:ADMLF) announces that it has received notice that on 26 September 2022 certain eligible Directors exercised options over ordinary shares in the Company resulting in the allotment on 26 September 2022 of 6,034,452 ordinary shares of £0.013355 each ("Shares"), as follows:

· Paul Cronin, CEO (via Dwellstone Limited, a company controlled by him) exercised 5,000,000 founder's options at the exercise price of A$0.20 per Share. The aggregate exercise price of A$1,000,000 was paid in cash to the Company. As a result, 5,000,000 Shares were issued and allotted to Dwellstone Limited. At Mr Cronin's request, 3,000,000 Shares will subsequently be transferred to members of Paul Cronin's family.

· Michael Rawlinson, Chairman, exercised 1,000,000 options at the exercise price of A$1.00 per Share, of which 100,000 were exercised with cash paid to the Company and 900,000 were effected by cashless exercise (with 403,122 Shares being withheld as part of the net settlement of the exercise price). As a result, 596,878 Shares were issued and allotted to Mr. Rawlinson, following which 224,918 Shares were sold at a price of A$1.91 per share in order to cover Mr Rawlinson's tax liabilities associated with the exercise.

· Sandra Bates, Non-Executive Director, exercised 1,000,000 options at the exercise price of A$1.25 per Share by cashless exercise (with 562,426 Shares being withheld as part of the net settlement of the exercise price). As a result, 437,574 Shares were issued and allotted to Ms. Bates, following which all such Shares were sold at a price of A$1.91 per Share, including a portion to cover Ms Bates's tax liabilities associated with the exercise.

· As a result of the above transactions, the total exercise proceeds received by the Company was A$1,100,000 as well as £12,480 representing the nominal value of the Shares acquired by Mr. Rawlinson and Ms Bates pursuant to the cashless exercise.

· These transactions complete the exercise of all outstanding options held by Mr. Rawlinson and Ms Bates. The Company does not plan to issue more options to Non-Executive Directors.

· Following the above exercises and sales, the number and approximate percentage of interest in shares in the Company held (directly and indirectly) by the above Directors are as shown below:

Director

Number of Shares Issued

Number of Shares Sold

Updated aggregate interest in ordinary shares

Approximate % of issued share capital

Paul Cronin

5,000,000

n/a

17,301,232

6.35%

Michael Rawlinson

596,878

(224,918)

411,960

0.15%

Sandra Bates

437,574

(437,574)

-

-

 

The Shares allotted rank pari passu in all respects with the existing ordinary shares of the Company.

In respect of the 5,000,000 Shares allotted on the exercise of Paul Cronin's options, applications will be made to the Financial Conduct Authority ("FCA") for admission of the Shares to the standard segment of the FCA's Official List and to the London Stock Exchange for admission of the Shares to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). Admission is expected to take place on or around 5 October 2022.

Admission of the 1,034,452 Shares allotted on the exercise of Mr Rawlinson's and Ms Bates's options takes place pursuant to the Company's existing block listing.

The Company confirms that as at the date of this announcement, the Company's issued share capital comprises 272,579,692 ordinary shares of £0.013355 each, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury. The above figure of 272,579,692 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in, the Company

Market Abuse Regulation Disclosure

The information contained within this announcement is deemed by Adriatic (LEI: 549300OHAH2GL1DP0L61) to constitute inside ‎information as stipulated under Article 7 of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK Market Abuse Regulation").

The person ‎responsible for arranging and authorising the release of this announcement on behalf of Adriatic is Paul Cronin, Managing Director and CEO.

 

 

**ends**

 

For further information please visit www.adriaticmetals.com; @AdriaticMetals on Twitter; or contact:

 

Adriatic Metals PLC

Paul Cronin / Klara Kaczmarek

Via Buchanan

Buchanan

Tel: +44 (0) 20 7466 5000

Bobby Morse/ Ariadna Peretz

adriatic@buchanan.uk.com 

Canaccord Genuity Limited (Joint Corporate Broker)

 

Jeremy Dunlop (Australia)

Tel: +61 2 9263 2700

James Asensio (UK)

Tel: +44 (0) 207 523 8000

RBC Capital Markets (Joint Corporate Broker)

 

Jamil Miah

Tel: +44 (0) 20 7653 4000

Stifel Nicolaus Europe Limited (Joint Corporate Broker)

Ashton Clanfield / Callum Stewart

Tel: +44 (0) 20 7710 7600

Citadel Magnus

Cameron Gilenko

Tel: +61 2 8234 0100

 

ABOUT ADRIATIC METALS

Adriatic Metals PLC (ASX:ADT, LSE:ADT1, OTCQX:ADMLF) is a precious and base metals developer that is advancing the world-class Vares Project in Bosnia & Herzegovina, as well as the Raska Project in Serbia.

The Vares Project is fully-funded to production, which is expected in Q2 2023. The 2021 Project Definitive Feasibility Study boasts robust economics of US$1,062 million post-tax NPV8, 134% IRR and a capex of US$168 million. Concurrent with ongoing construction activities, the Company continues to explore across its highly prospective 41km2 concession package.

There have been no material changes to the assumptions underpinning the forecast financial information derived from the production target in the 19 August 2021 DFS announcement and these assumptions continue to apply and have not materially changed. Adriatic Metals is not aware of any new information or data that materially affects the information included in the announcement of the updated Mineral Resource Estimate announced on 1 September 2020 and all material assumptions and technical parameters underpinning the Mineral Resource Estimate continue to apply and have not materially changed.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLRMATMTTTBMT
Date   Source Headline
25th Aug 20202:24 pmRNSApplication for Block Listing of Shares
25th Aug 20202:20 pmRNSApplication for Listing of Shares
24th Aug 20207:00 amRNSIncrease in Loan to Tethyan Resource Corp
21st Aug 20207:00 amRNSTethyan Resource Corp receives Court Approval
19th Aug 20207:00 amRNSCleansing Notice and Appendix 2A
18th Aug 20207:00 amRNSTethyan Resource receives Shareholder Approval
7th Aug 20207:00 amRNSISSUE OF PERFORMANCE RIGHTS
6th Aug 202012:02 pmRNSRegulatory Application
5th Aug 20207:41 amRNSStatement of CDIs in issue
3rd Aug 202011:58 amRNSAppendix 3X
3rd Aug 20207:00 amRNSNew Appointment and Board Changes
3rd Aug 20207:00 amRNSTotal Voting Rights
30th Jul 20206:02 pmRNSLitigation Proceedings commenced by Sandfire
30th Jul 20207:00 amRNSQuarterly Activities Report for 30 June 2020
28th Jul 20207:00 amRNSIssue of Equity
21st Jul 20207:00 amRNSIssue of Equity
20th Jul 20207:00 amRNSTethyan Resource information circular dispatched
14th Jul 20201:30 pmRNSTethyan Resource Corp. Obtains Interim Order
14th Jul 20207:00 amRNSAppendix 3Z
13th Jul 20207:00 amRNSIssue of Equity
10th Jul 20208:53 amRNSResponse to ASX Price Query
9th Jul 20207:00 amRNSResignation of Director
7th Jul 20207:00 amRNSStatement of CDIs in issue
1st Jul 20207:10 amRNSMines and Money Presentation
18th Jun 20207:00 amRNSStatement re Appendix 3Z
17th Jun 20205:15 pmRNSDirector/PDMR Dealing
15th Jun 20207:00 amRNSCorporate Governance Securities
15th Jun 20207:00 amRNSIssue of Performance Rights
15th Jun 20207:00 amRNSChange of Auditors
12th Jun 20208:30 amRNSArrangement Agreement
12th Jun 20207:00 amRNSManagement and Board Changes
4th Jun 20207:00 amRNSStatement of CDIs in issue
4th Jun 20207:00 amRNSIssue of Equity
3rd Jun 202012:19 pmRNSMinex Europe Presentation
26th May 20207:00 amRNSStatement re Environmental Permit Issue
15th May 20207:00 amRNSStatement re Director/PDMR Dealing
11th May 20207:00 amRNSAdriatic to acquire Tethyan Resource Corp
7th May 20207:00 amRNSStatement re: Statement of CDIs in issue
4th May 20207:00 amRNSStatement re Drill results for Rupice
4th May 20207:00 amRNSStatement re Escrow Securities Update
23rd Apr 20207:00 amRNSStatement re: Positive Record of Decision Received
22nd Apr 20209:33 amRNSStatement re Escrow Securities Update
8th Apr 20207:00 amRNSQuarterly Activities Report
3rd Apr 20207:00 amRNSStatement re Impact of COVID-19
3rd Apr 20207:00 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSGravity Data Reprocessing Highlights Anomalies
18th Mar 20207:00 amRNSIssue of Equity
11th Mar 20207:00 amRNSInterim Financial Statements
6th Mar 202011:46 amRNSTotal Voting Rights
2nd Mar 20207:00 amRNSISSUE OF EQUITY AND TOTAL VOTING RIGHTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.